March 25, 2022
Dr Jayasinghe awarded Richard King Prize

Dr Kushani Jayasinghe, Flagship clinician on the Genetic Kidney Disease Clinical Project, received the American College of Medical Genetics and Genomics (ACMG) Foundation’s 2022 Richard King Award for Best Publication by a Trainee.

The award highlights articles published by trainees who were either a first or corresponding author in the ACMG’s official journal, Genetics in Medicine.

Dr Jayasinghe’s paper on the work of the Kidney Flagship – Clinical impact of genomic testing in patients with suspected monogenic kidney disease – was considered to have the most merit out of all the articles published by trainees.

“I’m delighted to receive the Richard King Award,” said Dr Jayasinghe’.

“Genomic testing in kidney disease is still not routinely implemented into clinical practice. This study shows that genomics has considerable clinical utility and has significant implications for patients.”

“I am very grateful for Melbourne Genomics who funded this study, the many researchers and clinicians who contributed to this study, and my mentors who have supported me through my research and training,” said Dr Jayasinghe.

Dr. Kushani Jayasinghe is a nephrologist at Monash Health and is undertaking clinical genetics training at the Royal Melbourne Hospital. She received her medical degree from Monash University, fellowship of the Royal Australian College of Physicians, and has recently completed her doctoral studies on the clinical utility and feasibility of genomic sequencing in kidney disease.

Read the press release.

Read more about the publication.

Read about the Melbourne Genomics Genetic Kidney Disease Flagship.

Subscribe

We could talk genomics all day, but we’ll send you only what’s useful and interesting.

Melbourne Genomics acknowledges the Wurundjeri people of the Kulin Nation, on whose lands we work, and all First Nations peoples across Victoria. We pay respect to Elders past and present. We also acknowledge the First Nations health professionals, researchers and leaders who are shaping the future of genomic medicine.

© 2014–2022 Melbourne Genomics Health Alliance